PARADIGM-extensie

A multicenter study to evaluate safety and tolerability in patients with chronic heart failure and reduced ejection fraction from PARADIGM-HF receiving open label LCZ696

Stage: klaar
Medicine: LCZ696
Population: Hartfalen
Phase: extensie
First Patient In: 15 February 2015
Last Patient In: -
Last Patient Last Visit: -

Study Director

dr. A. Mosterd

Cardioloog